KRAS and neoplasm: At present, the main genetic driving factors of PDAC have been identified,7 of which KRAS is the main driver mutation, and the mutations of several other tumour suppressor genes such as TP53, CDKN2A, SMAD4, BRCA2 and TGFBR2 can promote tumour progression.